Aditxt, Inc. Derivative Liability, Noncurrent
Aditxt, Inc. (ADTX) had Derivative Liability, Noncurrent of $35.45 million as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-05-20
- 2026-03-31: Derivative Liability, Noncurrent $35.45M.
- 2025-12-31: Derivative Liability, Noncurrent $2.00.
- 2025-09-30: Derivative Liability, Noncurrent $230.00.
- 2025-06-30: Derivative Liability, Noncurrent $392.00.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2026-03-31 | $35.45M 10-Q · filed 2026-05-20 |
| 2025-12-31 | $2.00 10-Q · filed 2026-05-20 |
| 2025-09-30 | $230.00 10-Q · filed 2025-11-18 |
| 2025-06-30 | $392.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.37K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $14.52K 10-K · filed 2026-03-31 |
| 2024-09-30 | $429.02K 10-Q · filed 2024-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |